1.Eron, LJ, Lipsky, BA, Low, DE, Nathwani, D, Tice, AD, Volturo, GA. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003;52(suppl 1):i3–17.
2.DiNubile, M, Lipsky, BA. Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother 2004;53:ii37–ii50.
3.Ciccarone, D, Bamberger, JD, Krai, AH, et al. Soft tissue infections among injection drug users—San Francisco, California, 1996-2000. MMWR Morb Mortal Wkly Rep 2001;50:381–384.
4.Martone, WJ, Nichols, RL. Recognition, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis 2001;33:S67–S68.
5.Lipsky, BA, Berendt, , AR, , Deery, HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39:885–910.
6.Lazzarini, L, Conti, E, Tositti, G, de Lalla, F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect 2005;51:383–389.
7.Fridkin, SK, Gaynes, RP. Antimicrobial resistance in intensive care units. Clin Chest Med 1999;20:303–316.
8.Vinh, DC, Embil, JM. Rapidly progressive soft tissue infections. Lancet Infect Dis 2005;5:501–513.
9.Davis, JS. Management of bone and joint infections due to Staphylococcus aureus. Intern Med J 2005;35:S79–S96.
10.Carek, PJ, Dickerson, LM, Sack, JL. Diagnosis and management of osteomyelitis. Am Fam Physician 2001;63:2413–2420.
11.Doern, GV, Jones, RN, Pfaller, MA, Kugler, KC, Beach, ML. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Diagn Microbiol Infect Dis 1999;34:65–72.
12.Fluckiger, U, Widmer, AF. Epidemiology of methicillin-resistant Staphylococcus aureus. Chemotherapy 1999;45:121–134.
13.Dang, CN, Prasad, YD, Boulton, AJ, Jude, EB. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 2003;20:159–161.
14.Mantey, I, Hill, RL, Foster, AV, Wilson, S, Wade, JJ, Edmonds, ME. Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients. Comm Dis Public Health 2000;3:288–290.
15.Moran, GJ, Krishnadasan, A, Gorwitz, RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–674.
16.Engemann, , JJ, , Carmeli, Y, Cosgrove, SE. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592–598.
17.Iezzoni, LI, Ash, AS, Coffman, GA, Moskowitz, MA. Admission and mid-stay Medis Groups scores as predictors of hospitalization charges. Med Care 1991;29:210–220.
18.Fine, MJ, Auble, TE, Yealy, DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–250.
19.Rello, J, Ollendorf, DA, Oster, G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115–2121.
20.Kollef, MH, Shorr, A, Tabak, YP, Gupta, V, Liu, LZ, Johannes, RS. Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854–3862.
21.Tabak, YT, Johannes, RS, Silber, JH. Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance. Med Care 2007;45:789–805.
22.Office of Drug Evaluation IV, US Food and Drug Administration. Guidance for industry: uncomplicated and complicated skin and skin structure infections—developing antimicrobial drugs for treatment (draft). 1998. Available at: http://www.fda.gov/ohrms/dockets/98fr/2566dft.pdf. Accessed December 30, 2006.
23.Solomkin, JS, Bjornson, HS, Cainzos, M, et al. A consensus statement on empiric therapy for suspected gram-positive infections in surgical patients. Am J Surg 2004;187:134–145.
24.Stevens, DL, Bisno, AL, Chambers, HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373–1406.
25.National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001;29:404–421.
26.Rennie, , RP, , Jones, , RN, , Mutnick, , AH, . Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn Microbiol Infect Dis 2003;45:287–293.
27.Rybak, MJ, LaPlante, KL. Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 2005;25:74–85.
28.Szumowski, JD, Cohen, DE, Kanaya, F, Mayer, KH. Treatment and outcomes of MRSA infections at an ambulatory clinic. Antimicrob Agents Chemother 2007;51:423–428.
29.Skiest, DJ, Brown, K, Cooper, TW, Hoffman-Roberts, H, Mussa, HR, Elliott, AC. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect 2007;54:427–434.
30.Crum, NF, Lee, RU, Thornton, SA, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006;119:943–951.
31.Fejfarova, V, Jirkovska, A, Skibova, J, Petkov, V. Pathogen resistance and other risk factors in the frequency of lower limb amputations in patients with diabetes foot syndrome [in Czech]. Vnitr Lek 2002;48:302–306.
32.Saravolatz, LD, Markowitz, N, Arking, L, Pohlod, D, Fisher, E. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982;96:11–16.
33.Cosgrove, SE, Sakoulas, G, Perencevich, EN, Schwaber, MJ, Karchmer, AW, Carmeli, Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a metaanalysis. Clin Infect Dis 2003;36:53–59.
34.Lesens, O, Methlin, C, Hansmann, Y, et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003;24:890–896.
35.Kozak, LJ, Owings, MF, Hall, MJ. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Division of Health Care Statistics, National Center for Health Statistics. Hyattsville, MD: Department of Health and Human Services (DHHS);2005. Vital and Health Statistics Series 13, No. 158. DHHS publication 2005-1729. Available at: http://www.cdc.gov/nchs/data/series/sr_13/srl3_158.pdf. Accessed December 30, 2006.
36.Ramsey, SD, Newton, K, Blough, D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382–387.
37.Lavery, LA, Armstrong, DA, Wunderlich, RP, Möhler, MJ, Wendel, CS, Lipsky, BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006;29:1288–1293.
38.Henke, PK, Blackburn, SA, Wainess, RW, et al. Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg 2005;241:885–894.